GSK Says Execs May Have Broken Chinese Bribery Laws
U.K. drugmaker GlaxoSmithKline PLC announced Monday that some of its senior executives in China may have violated the law in an alleged bribery scandal in which Chinese officials claim the company...To view the full article, register now.
Already a subscriber? Click here to view full article